Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opexa Therapeutics Inc (NASDAQ:OPXA)

1.08
Delayed Data
As of Feb 21
 -0.02 / -1.82%
Today’s Change
0.50
Today|||52-Week Range
4.93
+17.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.9M

Company Description

Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.

Contact Information

Opexa Therapeutics, Inc.
2635 Technology Forest Boulevard
The Woodlands Texas 77381
P:(281) 775-0600
Investor Relations:

Employees

Shareholders

Other institutional4.13%
Individual stakeholders3.51%
Mutual fund holders1.69%

Top Executives

Neil K. WarmaPresident, Chief Executive Officer, CFO & Director